Stockreport

Novo Nordisk Targets Japan Self-Pay Market as Only 14,000 Access Obesity Drugs [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Novo Nordisk ( NYSE:NVO ) is testing a new route to unlock obesity drug demand in Japan, where strict reimbursement rules have slowed uptake despite rising global inter [Read more]